Table 2.

In vitro cytokine-stimulated cell expansion from sorted KLS cells

Cytokine cocktailWT KLS
6d-fold expansion
STAT5ab−/−KLS
6d-fold expansion
STAT5ab−/−
-fold reduction
P
IL36S 1164 ± 213 138 ± 116 8.4 <.01 
IL3SFT 1012 ± 624 79 ± 81 12.8 .05 
IL3S 749 ± 455 73 ± 43 10.3 .05 
IL3F 182 ± 40 85 ± 74 2.1 .12 
IL3T 213 ± 182 39 ± 19 5.5 .16 
SFT 76 ± 26 22 ± 21 3.5 .02 
Cytokine cocktailWT KLS
6d-fold expansion
STAT5ab−/−KLS
6d-fold expansion
STAT5ab−/−
-fold reduction
P
IL36S 1164 ± 213 138 ± 116 8.4 <.01 
IL3SFT 1012 ± 624 79 ± 81 12.8 .05 
IL3S 749 ± 455 73 ± 43 10.3 .05 
IL3F 182 ± 40 85 ± 74 2.1 .12 
IL3T 213 ± 182 39 ± 19 5.5 .16 
SFT 76 ± 26 22 ± 21 3.5 .02 

KLS cells were sorted by FACS and plated in 96-well plates in the presence of various cytokine cocktails. After 6 days in culture, the total nucleated cell count was determined using a hemacytometer. The fold cell expansion was calculated based on the starting number of cells seeded per well.

IL3 indicates murine interleukin 3 (20 ng/mL); 6, human interleukin 6 (50 ng/mL); S, murine stem cell factor (50 ng/mL); F, murine flt-3 ligand (50 ng/mL); and T, murine thrombopoietin (50 ng/mL). The results are the averages ± SD for 4 to 6 experiments.

Close Modal

or Create an Account

Close Modal
Close Modal